Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
CALL
Alphatec Holdings
ATEC
$1.48B
| $9.75M | 0.01% |
+800,000
| New | +$11.2M |
|
|
LCAA
2052
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
| $9.75M | 0.01% |
1,002,061
+703,688
| +236% | +$6.83M |
|
|
FPAC
2053
DELISTED
Far Peak Acquisition Corporation
FPAC
| $9.75M | 0.01% |
979,520
+940,646
| +2,420% | +$9.36M |
|
2054
PUT
MSCI
MSCI
$41.4B
| $9.73M | 0.01% |
16,000
+14,700
| +1,131% | +$8.98M |
|
|
TRIL
2055
DELISTED
Trillium Therapeutics Inc.
TRIL
| $9.73M | 0.01% |
553,684
+345,612
| +166% | +$4.04M |
|
2056
AlTi Global
ALTI
$456M
| $9.73M | 0.01% |
987,798
+449,791
| +84% | +$4.37M |
|
|
EB
2057
DELISTED
Eventbrite
EB
| $9.72M | 0.01% |
514,303
-871,836
| -63% | -$15.3M |
|
|
RADI
2058
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $9.72M | 0.01% |
595,376
+541,308
| +1,001% | +$8.7M |
|
2059
PUT
Prudential Financial
PRU
$41.5B
| $9.72M | 0.01% |
92,400
-6,200
| -6% | -$639K |
|
2060
Ultragenyx Pharmaceutical
RARE
$2.59B
| $9.72M | 0.01% |
107,764
-455,623
| -81% | -$41.2M |
|
|
AAWW
2061
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $9.72M | 0.01% |
118,970
-5,330
| -4% | -$384K |
|
|
EAR
2062
DELISTED
Eargo, Inc. Common Stock
EAR
| $9.7M | 0.01% |
72,063
+19,038
| +36% | +$10.2M |
|
2063
PUT
Axsome Therapeutics
AXSM
$10.8B
| $9.69M | 0.01% |
+293,900
| New | +$11.5M |
|
2064
Envoy Medical
COCH
$56.4M
| $9.67M | 0.01% |
996,037
+15,396
| +2% | +$149K |
|
|
ACRE
2065
Ares Commercial Real Estate
ACRE
$257M
| $9.67M | 0.01% |
641,320
-239,328
| -27% | -$3.63M |
|
|
SWAGU
2066
DELISTED
Software Acquisition Group Inc. III Unit
SWAGU
| $9.66M | 0.01% |
+956,529
| New | +$9.61M |
|
2067
CALL
NeoGenomics
NEO
$2.39B
| $9.65M | 0.01% |
+200,000
| New | +$9.26M |
|
|
TWTR
2068
DELISTED
Twitter, Inc.
TWTR
| $9.65M | 0.01% |
159,763
-482,300
| -75% | -$31.7M |
|
2069
CALL
Renaissance IPO ETF
IPO
$154M
| $9.65M | 0.01% |
+150,000
| New | +$9.77M |
|
|
2070
PUT
Renaissance IPO ETF
IPO
$154M
| $9.65M | 0.01% |
+150,000
| New | +$9.77M |
|
2071
Sabre
SABR
$864M
| $9.64M | 0.01% |
813,913
+766,971
| +1,634% | +$8.7M |
|
2072
CALL
iShares Core Dividend Growth ETF
DGRO
$43.6B
| $9.64M | 0.01% |
191,800
+91,800
| +92% | +$4.75M |
|
2073
GoPro
GPRO
$112M
| $9.63M | 0.01% |
1,029,316
-794,680
| -44% | -$8.03M |
|
2074
CBIZ
CBZ
$2.97B
| $9.63M | 0.01% |
297,877
+242,013
| +433% | +$7.88M |
|
|
BRDG
2075
DELISTED
Bridge Investment Group
BRDG
| $9.63M | 0.01% |
+544,887
| New | +$9.39M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.